Gene Closes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gene closes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gene Closes Today - Breaking & Trending Today

Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene


Published: May 05, 2021
By Mark Terry
There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look.
Esker Launches with $70 Million Series A
San Francisco-based Esker Therapeutics, a Foresite Labs-incubated company,
launched with a $70 million Series A financing. The round was led by Foresite Capital. The company focuses on autoimmune diseases and so-called precision therapies that target patients most likely to benefit from them.
The company’s precision analytics platform is powered by Foresite Labs. The technology platform is made up of high-quality curated genetic, clinical and medical record data, a systems immunology approach for prospective data collections and tools for building patient registries. Its lead pipeline product is ESK-001, a highly selective TYK2 inhibitor with greater selectivity for TYK2 over JAK1, initially in development for psoriasis. It is ....

United Kingdom , North Carolina , United States , Duke University , Jonathan Milner , Kelli Luginbuhl , June Lee , Ashutosh Chilkoti , Joe Mcmahon , Isolere Bio , Darrinm Disley , Carolina Biotech Center , National Institutes Of Health , National Science Foundation , Esker Therapeutics , Foresite Labs Incubated , Mogrify Limited , Parkwalk Advisors , Astellas Venture Management , Jonathan Miler , Bio Raises , National Institutes , North Carolina Biotech , Gene Closes , California Based Bridgene , Wedo Venture Partners ,